Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Gross Margin (2009)

Updated

Kazia Therapeutics (KZIA) reported Gross Margin of 107.31% for FY2011 (year ended Jun 30, 2011), up 7.31 percentage points from 100.00% in FY2010.

Analysis

Kazia Therapeutics (KZIA) Gross Margin (2009) Analysis & Trends

  • According to Business Quant data, Gross Margin came in at 100.00% in FY2010 (+22.63 pp) and 77.37% in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 68.12%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 75.38%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 72.95%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 88.03%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 73.10%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 81.07%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 75.71%
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2009 63.22%
API Access

Kazia Therapeutics Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=KZIA&period=max&api_key=YOUR_API_KEY